Melanoma Clinical Trial

Clinical Trial Finder Melanoma Trials

Cost of Adverse Events Related to How Often Follow-Up Occurs Among Patients With Cancer That Has Spread

See Locations Near You

Summary

This study is a real-world retrospective claims analysis to assess and compare AE-related HCRU and medical costs among patients with different follow-up frequency after initiating a melanoma therapy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Diagnosed with metastatic melanoma
Initiated at least 1 treatment for metastatic melanoma after 2011
Continuous enrollment in their healthcare plan for at least 6 months before and at least 6 weeks after the index date
Patients who received at least 1 dose of study drug in CA209-067

Study is for people with:

Melanoma

Estimated Enrollment:

1828

Study ID:

NCT03165409

Recruitment Status:

Completed

Sponsor:

Bristol-Myers Squibb

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Bristol-Myers Squibb
Princeton New Jersey, 08540, United States

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

1828

Study ID:

NCT03165409

Recruitment Status:

Completed

Sponsor:


Bristol-Myers Squibb

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider